Efficacy analysis of microvascular decompression and percutaneous balloon compression for trigeminal neuralgia secondary to vertebrobasilar dolichoectasia: a retrospective cohort study - Scorecard - MDSpire
Advertisement
Efficacy analysis of microvascular decompression and percutaneous balloon compression for trigeminal neuralgia secondary to vertebrobasilar dolichoectasia: a retrospective cohort study
Clinical Scorecard: Comparative Effectiveness of Microvascular Decompression versus Percutaneous Balloon Compression for Trigeminal Neuralgia Associated with Vertebrobasilar Dolichoectasia: A Retrospective Cohort Analysis
At a Glance
Category
Detail
Condition
Trigeminal neuralgia secondary to vertebrobasilar dolichoectasia (VBD-TN)
Key Mechanisms
Compression of the trigeminal nerve root by tortuous, elongated vertebrobasilar arteries causing neuropathic facial pain
Target Population
Patients diagnosed with trigeminal neuralgia associated with vertebrobasilar dolichoectasia
Care Setting
Neurosurgical and interventional pain management settings in tertiary hospitals
Key Highlights
VBD-TN is a rare subtype of trigeminal neuralgia, accounting for 2% to 7.7% of TN cases.
Microvascular decompression (MVD) is the preferred surgical treatment for classical TN but is technically challenging in VBD-TN due to vascular tortuosity.
Percutaneous balloon compression (PBC) offers a minimally invasive alternative with simpler procedural complexity for VBD-TN management.
Guideline-Based Recommendations
Diagnosis
Confirm trigeminal neuralgia diagnosis based on clinical criteria.
Use 3D time-of-flight magnetic resonance angiography (3D-TOF-MRA) to identify vertebrobasilar dolichoectasia and neurovascular compression.
Exclude secondary causes of trigeminal neuralgia and prior MVD or PBC treatments.
Management
Select MVD for patients without contraindications who accept craniotomy risks and have low tolerance for postoperative numbness.
Select PBC for patients with contraindications to MVD, those refusing craniotomy, or with high tolerance for postoperative numbness.
Perform MVD via retrosigmoid approach with microscope-endoscope assistance, placing Teflon pledgets between vessel and nerve; consider selective partial posterior rhizotomy if decompression is difficult.
Perform PBC via percutaneous foramen ovale puncture under image guidance, inflating balloon in Meckel’s cave to compress trigeminal ganglion for 120–180 seconds.
Monitoring & Follow-up
Follow up patients at 1, 6, and 12 months postoperatively, then annually via outpatient visits or telemedicine.
Assess pain relief using Barrow Neurological Institute (BNI) scoring system.
Monitor for perioperative complications including intracranial infection, cerebrospinal fluid leakage, incision infection, facial numbness, facial paralysis, dry eyes, double vision, hearing loss, and tinnitus.
Risks
MVD carries risks related to craniotomy and manipulation of tortuous vertebrobasilar arteries.
PBC risks include facial numbness and potential for incomplete pain relief.
Contraindications for MVD include local infection, frail constitution, or contralateral hearing impairment.
Contraindications for PBC include abnormal foramen ovale anatomy and active craniofacial infections.
Patient & Prescribing Data
Patients with VBD-associated trigeminal neuralgia undergoing surgical intervention
Treatment choice guided by contraindications, patient preference regarding craniotomy risks and postoperative numbness tolerance, with both MVD and PBC performed by experienced surgeons.
Clinical Best Practices
Use detailed preoperative imaging to confirm neurovascular compression and VBD diagnosis.
Tailor surgical approach based on patient-specific contraindications and preferences.
Employ combined microscope and endoscope assistance during MVD for optimal visualization.
Ensure precise image-guided puncture and balloon placement during PBC to achieve effective compression.
Conduct thorough documentation of surgical details, complications, and follow-up outcomes.